Insulin detemir Subcutaneous and Zoledronic Acid (Bone Health)
Determining the interaction of Insulin detemir Subcutaneous and Zoledronic Acid (Bone Health) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin detemir
Brand name: Levemir, Levemir FlexPen, Levemir PenFill, Levemir InnoLet, Levemir FlexTouch
Synonyms: Insulin detemir, Insulin Detemir
Generic Name: zoledronic acid
Brand name: Reclast, Zometa, Zometa Concentrate, Aclasta
Synonyms: Zoledronic acid, Zoledronic Acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin detemir Subcutaneous-Zoledronic Acid (Zometa)
- Insulin detemir Subcutaneous-Zoledronic Acid Injection
- Insulin detemir Subcutaneous-Zoledronic Acid Injection Concentrate
- Insulin detemir Subcutaneous-Zoledronic acid Intravenous
- Insulin detemir Subcutaneous-Zoledronic Acid IV
- Insulin detemir Subcutaneous-Zolgensma
- Zoledronic Acid (Bone Health)-Insulin glargine
- Zoledronic Acid (Bone Health)-Insulin Glargine (U-100) Cartridge Systems and Pens
- Zoledronic Acid (Bone Health)-Insulin Glargine (U-100) Vials
- Zoledronic Acid (Bone Health)-Insulin Glargine (U-300) Pens
- Zoledronic Acid (Bone Health)-Insulin glargine and lixisenatide
- Zoledronic Acid (Bone Health)-Insulin glargine and lixisenatide Subcutaneous